Differences in the phenotypes and transcriptomic signatures of chimeric antigen receptor T lymphocytes manufactured via electroporation or lentiviral transfection

Chimeric antigen receptor (CAR)-T cell therapy is an innovative treatment for CD19-expressing lymphomas. CAR-T cells are primarily manufactured via lentivirus transfection or transposon electroporation. While anti-tumor efficacy comparisons between the two methods have been conducted, there is a cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Anna, Zou, Jintao, Hu, Xuan, Zhang, Zhang, Su, Lingyu, Wang, Jing, Lu, Xing, Zhang, Wei, Chen, Wei, Zhang, Xiaopeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203401/
https://www.ncbi.nlm.nih.gov/pubmed/37228617
http://dx.doi.org/10.3389/fimmu.2023.1068625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203401/
https://www.ncbi.nlm.nih.gov/pubmed/37228617
http://dx.doi.org/10.3389/fimmu.2023.1068625

Ejemplares similares